FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis
FRA:FRE - DE0005785604 - Common Stock
46.82 EUR
-0.36 (-0.76%)
FRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 28 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FRE get a neutral evaluation. Nothing too spectacular is happening here. FRE is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year FRE was profitable.
In the past year FRE had a positive cash flow from operations.
FRE had positive earnings in 4 of the past 5 years.
FRE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
FRE has a Return On Assets of 2.72%. This is comparable to the rest of the industry: FRE outperforms 53.57% of its industry peers.
The Return On Equity of FRE (6.15%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.29%, FRE is doing worse than 60.71% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FRE is below the industry average of 6.48%.
The 3 year average ROIC (1.83%) for FRE is below the current ROIC(3.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.72% | ||
| ROE | 6.15% | ||
| ROIC | 3.29% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
1.3 Margins
The Profit Margin of FRE (5.06%) is better than 82.14% of its industry peers.
In the last couple of years the Profit Margin of FRE has declined.
FRE's Operating Margin of 9.96% is amongst the best of the industry. FRE outperforms 82.14% of its industry peers.
In the last couple of years the Operating Margin of FRE has declined.
The Gross Margin of FRE (25.40%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of FRE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.96% | ||
| PM (TTM) | 5.06% | ||
| GM | 25.4% |
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
Compared to 1 year ago, FRE has about the same amount of shares outstanding.
FRE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, FRE has an improved debt to assets ratio.
2.2 Solvency
FRE has an Altman-Z score of 2.09. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.09, FRE is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
FRE has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as FRE would need 10.07 years to pay back of all of its debts.
FRE's Debt to FCF ratio of 10.07 is in line compared to the rest of the industry. FRE outperforms 46.43% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.61, FRE is doing good in the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 2.09 |
ROIC/WACC0.63
WACC5.19%
2.3 Liquidity
FRE has a Current Ratio of 1.31. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
FRE has a better Current ratio (1.31) than 64.29% of its industry peers.
A Quick Ratio of 1.00 indicates that FRE may have some problems paying its short term obligations.
FRE's Quick ratio of 1.00 is fine compared to the rest of the industry. FRE outperforms 60.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1090.91%, which is quite impressive.
The Earnings Per Share has been decreasing by -2.29% on average over the past years.
Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 0.89% in the last year.
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)1090.91%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%6.17%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
3.2 Future
The Earnings Per Share is expected to grow by 9.84% on average over the next years. This is quite good.
FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.86% yearly.
EPS Next Y10.11%
EPS Next 2Y10.73%
EPS Next 3Y10.03%
EPS Next 5Y9.84%
Revenue Next Year4.76%
Revenue Next 2Y4.85%
Revenue Next 3Y4.85%
Revenue Next 5Y4.86%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.32, FRE is valued correctly.
71.43% of the companies in the same industry are more expensive than FRE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.06, FRE is valued a bit cheaper.
With a Price/Forward Earnings ratio of 12.69, FRE is valued correctly.
FRE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FRE is cheaper than 71.43% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.69. FRE is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.32 | ||
| Fwd PE | 12.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, FRE is valued a bit more expensive than the industry average as 60.71% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, FRE is valued a bit more expensive than 67.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.68 | ||
| EV/EBITDA | 10.31 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.42
PEG (5Y)N/A
EPS Next 2Y10.73%
EPS Next 3Y10.03%
5. Dividend
5.1 Amount
FRE has a Yearly Dividend Yield of 2.12%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.70, FRE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, FRE has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.12% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
58.31% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP58.31%
EPS Next 2Y10.73%
EPS Next 3Y10.03%
FRA:FRE (9/5/2025, 7:00:00 PM)
46.82
-0.36 (-0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners36.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.37B
Analysts85.22
Price Target50.39 (7.62%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.12% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP58.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.26%
Min EPS beat(2)8.91%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.92%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.85%
EPS beat(12)6
Avg EPS beat(12)-41.15%
EPS beat(16)8
Avg EPS beat(16)-31.82%
Revenue beat(2)2
Avg Revenue beat(2)2.07%
Min Revenue beat(2)1.31%
Max Revenue beat(2)2.84%
Revenue beat(4)4
Avg Revenue beat(4)1.74%
Min Revenue beat(4)0.41%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.11%
Revenue beat(16)6
Avg Revenue beat(16)0%
PT rev (1m)1.87%
PT rev (3m)3.06%
EPS NQ rev (1m)-0.66%
EPS NQ rev (3m)7.2%
EPS NY rev (1m)0.01%
EPS NY rev (3m)0.01%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.32 | ||
| Fwd PE | 12.69 | ||
| P/S | 1.19 | ||
| P/FCF | 20.68 | ||
| P/OCF | 11.73 | ||
| P/B | 1.44 | ||
| P/tB | 18.14 | ||
| EV/EBITDA | 10.31 |
EPS(TTM)3.27
EY6.98%
EPS(NY)3.69
Fwd EY7.88%
FCF(TTM)2.26
FCFY4.83%
OCF(TTM)3.99
OCFY8.53%
SpS39.46
BVpS32.46
TBVpS2.58
PEG (NY)1.42
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.72% | ||
| ROE | 6.15% | ||
| ROCE | 6.7% | ||
| ROIC | 3.29% | ||
| ROICexc | 3.6% | ||
| ROICexgc | 7.96% | ||
| OM | 9.96% | ||
| PM (TTM) | 5.06% | ||
| GM | 25.4% | ||
| FCFM | 5.74% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexcg growth 3Y-17.75%
ROICexcg growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score8
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 3.32 | ||
| Cap/Depr | 86.89% | ||
| Cap/Sales | 4.38% | ||
| Interest Coverage | 6.1 | ||
| Cash Conversion | 67.46% | ||
| Profit Quality | 113.33% | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.09 |
F-Score8
WACC5.19%
ROIC/WACC0.63
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1090.91%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%6.17%
EPS Next Y10.11%
EPS Next 2Y10.73%
EPS Next 3Y10.03%
EPS Next 5Y9.84%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.76%
Revenue Next 2Y4.85%
Revenue Next 3Y4.85%
Revenue Next 5Y4.86%
EBIT growth 1Y69.58%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.74%
EBIT Next 3Y23.83%
EBIT Next 5Y15.64%
FCF growth 1Y-50.31%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-49.36%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%